journal article·2023-09

Monocyte Differentiation‐Surveilling Nano‐Shuttles for Activatable Targeted Inhibition of Atherosclerotic Plaque Progression

Chenxing Fu, Ying Tao, Haoting Chen, Minghui Li, Yafang Xiao, Yuying Yao, Jing Ma, Xiaodong Ning, Weirun Li, Jun Zheng, Songbo Dong, Guoqin Chen, Feng Cao, Caiwen Ou, Lu Liu, Weisheng Guo

Advanced Functional Materials· Volume 33· Issue 37
Publisher page

Abstract

Abstract Atherosclerosis can form intimal plaques in the arteries and undergo plaque rupture with followed stroke or myocardial infarction under certain pathological conditions. However, suboptimal intraplaque accumulation, along with severe off‐target effects, remain formidable obstacles for efficient pharmacotherapy of atherosclerosis. A characteristic feature of the progression of atherosclerosis is the continuous recruitment of inflammatory monocytes that differentiate into foamy macrophages with the generation of legumain in the plaques. In this study, a bio‐activatable nano‐shuttle based on human serum albumin is conceived that contained curcumin to allow the precise inhibition of atherosclerosis progression. Following intravenous injection, the nano‐shuttles are almost exclusively engulfed by inflammatory monocytes in an efferocytosis‐mimetic manner and selectively co‐migrated with the monocytes towards the plaques. The nano‐shuttles are readily activated to release the initially arrested curcumin in response to the generation of legumain upon the differentiation of monocytes into foamy macrophages within the plaques. Treatment assessments on atheroprone apolipoprotein‐E‐deficient mice indicated that the nano‐shuttles substantially inhibit the progression of atherosclerosis by attenuating the plaque inflammation burden without any obvious adverse effects. The integration of highly selective accumulation and specific drug activation of the nano‐shuttles in plaques can arouse an advanced therapeutic strategy to prevent atherosclerotic cardiovascular disease.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Protease and Inhibitor Mechanisms · Atherosclerosis and Cardiovascular Diseases · Cell Adhesion Molecules Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Minimally Invasive Interventional Radiology School of Biomedical Engineering & The Second Affiliated Hospital Guangzhou Medical University Guangzhou 510260 China

Laboratory of Controllable Nanopharmaceuticals Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety National Center for Nanoscience and Technology Beijing 100190 China

The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital) Southern Medical University Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation Dongguan 523018 China

Department of Cardiac Surgery Beijing Anzhen Hospital Capital Medical University Beijing 100029 China

Cardiology Department of Panyu Central Hospital and Cardiovascular Disease Institute of Panyu District Guangzhou 511400 China

Department of Cardiology National Clinical Research Center for Geriatric Diseases & Second Medical Center of Chinese PLA General Hospital Beijing 100853 China

Funding

National Natural Science Foundation of China

References (49)

Show source-provided references
1. 10.1016/j.jacc.2020.11.01010.1016/j.jacc.2020.11.010 ↗
2. 10.1161/CIRCULATIONAHA.119.04165310.1161/CIRCULATIONAHA.119.041653 ↗
3. 10.1016/j.jacc.2019.10.00910.1016/j.jacc.2019.10.009 ↗
4. 10.1161/ATVBAHA.116.30799310.1161/ATVBAHA.116.307993 ↗
5. 10.1016/j.jacc.2019.08.01210.1016/j.jacc.2019.08.012 ↗
6. 10.1161/hc0902.10435310.1161/hc0902.104353 ↗
7. 10.1038/nature0132310.1038/nature01323 ↗
8. 10.1016/j.jacc.2019.03.01010.1016/j.jacc.2019.03.010 ↗
9. 10.1016/j.jacc.2021.06.01110.1016/j.jacc.2021.06.011 ↗
10. 10.1016/j.nantod.2014.04.00810.1016/j.nantod.2014.04.008 ↗
11. 10.1161/01.CIR.0000140720.79015.3C10.1161/01.CIR.0000140720.79015.3C ↗
12. 10.1021/acsnano.0c0024510.1021/acsnano.0c00245 ↗
13. 10.1021/acsnano.8b0887510.1021/acsnano.8b08875 ↗
14. 10.1016/j.jacc.2018.08.215010.1016/j.jacc.2018.08.2150 ↗
15. 10.1038/nrcardio.2009.22810.1038/nrcardio.2009.228 ↗
16. 10.1016/j.jacc.2018.08.214710.1016/j.jacc.2018.08.2147 ↗
17. 10.1038/nri352010.1038/nri3520 ↗
18. 10.1161/CIRCRESAHA.115.30625610.1161/CIRCRESAHA.115.306256 ↗
19. 10.1016/j.cell.2011.04.00510.1016/j.cell.2011.04.005 ↗
20. 10.1038/s41565-019-0619-310.1038/s41565-019-0619-3 ↗
21. 10.1016/j.gene.2018.02.01210.1016/j.gene.2018.02.012 ↗
22. 10.1016/j.atherosclerosis.2008.01.01610.1016/j.atherosclerosis.2008.01.016 ↗
23. 10.1016/j.tcb.2015.08.00310.1016/j.tcb.2015.08.003 ↗
24. 10.1038/nature0630710.1038/nature06307 ↗
25. 10.1016/j.tibs.2017.06.00410.1016/j.tibs.2017.06.004 ↗
26. 10.1007/s10741-018-09764-z10.1007/s10741-018-09764-z ↗
27. 10.1016/j.atherosclerosis.2013.10.01610.1016/j.atherosclerosis.2013.10.016 ↗
28. 10.1021/acsnano.5b0028710.1021/acsnano.5b00287 ↗
29. 10.1021/acs.nanolett.7b0233010.1021/acs.nanolett.7b02330 ↗
30. 10.1016/j.atherosclerosis.2016.11.02610.1016/j.atherosclerosis.2016.11.026 ↗
31. 10.3390/ijms2009219510.3390/ijms20092195 ↗
32. 10.1016/j.jacc.2011.07.01710.1016/j.jacc.2011.07.017 ↗
33. 10.1016/j.cellimm.2014.07.00710.1016/j.cellimm.2014.07.007 ↗
34. 10.1016/j.jacc.2018.08.214810.1016/j.jacc.2018.08.2148 ↗
35. 10.1038/nnano.2014.6210.1038/nnano.2014.62 ↗
36. 10.1080/20013078.2019.170670810.1080/20013078.2019.1706708 ↗
37. 10.1148/radiol.244105176910.1148/radiol.2441051769 ↗
38. 10.1161/01.CIR.0000028591.44554.F910.1161/01.CIR.0000028591.44554.F9 ↗
39. 10.1016/S0735-1097(98)00170-310.1016/S0735-1097(98)00170-3 ↗
40. 10.1038/s41572-019-0106-z10.1038/s41572-019-0106-z ↗
41. 10.1161/CIRCULATIONAHA.116.02568410.1161/CIRCULATIONAHA.116.025684 ↗
42. 10.1093/eurheartj/ehv65310.1093/eurheartj/ehv653 ↗
43. 10.1016/j.plipres.2011.04.00210.1016/j.plipres.2011.04.002 ↗
44. 10.1016/j.cell.2007.08.02410.1016/j.cell.2007.08.024 ↗
45. 10.1021/nn405878710.1021/nn4058787 ↗
46. 10.1016/j.arr.2021.10136410.1016/j.arr.2021.101364 ↗
47. 10.1016/j.biomaterials.2013.12.09010.1016/j.biomaterials.2013.12.090 ↗
48. 10.1039/C4CC03139C10.1039/C4CC03139C ↗
49. 10.7150/thno.2436410.7150/thno.24364 ↗